Management of Diabetic Ketoacidosis in Patients with Diabetes Type I
Basam, Z., Alazwari, N., Khateeb, A., Alzaher, A., Alkhawajah, M., Almutairi, A., Al-Mutairi, N., Alghanim, Z., Nemer, A., Khatib, H. (2017). Management of Diabetic Ketoacidosis in Patients with Diabetes Type I. EKB Journal Management System, 69(4), 2278-2285. doi: 10.12816/0041530
Zuhaer Sindi Basam; Naif Mishkhas Alazwari; Abdulaziz Mohammed Khateeb; Aqil Abdulmonem Alzaher; Mohammad Abdulaziz M Alkhawajah; Atheer Khalid Almutairi; Najd Abdulrahman Al-Mutairi; Zainab Reda Alghanim; Ameera Ahmad Nemer; Hazim Abdulkarim Khatib. "Management of Diabetic Ketoacidosis in Patients with Diabetes Type I". EKB Journal Management System, 69, 4, 2017, 2278-2285. doi: 10.12816/0041530
Basam, Z., Alazwari, N., Khateeb, A., Alzaher, A., Alkhawajah, M., Almutairi, A., Al-Mutairi, N., Alghanim, Z., Nemer, A., Khatib, H. (2017). 'Management of Diabetic Ketoacidosis in Patients with Diabetes Type I', EKB Journal Management System, 69(4), pp. 2278-2285. doi: 10.12816/0041530
Basam, Z., Alazwari, N., Khateeb, A., Alzaher, A., Alkhawajah, M., Almutairi, A., Al-Mutairi, N., Alghanim, Z., Nemer, A., Khatib, H. Management of Diabetic Ketoacidosis in Patients with Diabetes Type I. EKB Journal Management System, 2017; 69(4): 2278-2285. doi: 10.12816/0041530

Management of Diabetic Ketoacidosis in Patients with Diabetes Type I

The Egyptian Journal of Hospital Medicine
Article 17, Volume 69, Issue 4, October 2017, Page 2278-2285  XML PDF (271.38 K)
Document Type: Original Article
DOI: 10.12816/0041530
View on SCiNiTO View on SCiNiTO
Authors
Zuhaer Sindi Basam1; Naif Mishkhas Alazwari2; Abdulaziz Mohammed Khateeb2; Aqil Abdulmonem Alzaher3; Mohammad Abdulaziz M Alkhawajah3; Atheer Khalid Almutairi3; Najd Abdulrahman Al-Mutairi3; Zainab Reda Alghanim3; Ameera Ahmad Nemer3; Hazim Abdulkarim Khatib4
1Umm Alqura University
2King Abdulaziz University,
3Imam Abdulrahman Bin Faisal University
4King Abdulaziz University
Abstract
Background: DKA is the leading cause of mortality among pediatric age and young adults with T1D, responsible for almost 50% of all fatalities in diabetic patients younger than 24 years of age. Goals of DKA management include optimization of volume status, hyperglycemia and ketoacidosis, electrolyte abnormalities, and potential precipitating factors. Methodology: we conducted this review using a comprehensive search of MEDLINE, PubMed, and EMBASE, January 1987, through February 2017. The following search terms were used: ketoacidosis, management of diabetic ketoacidosis, type I diabetic patients’ emergency complication, fluid replacement in DKA, insulin therapy approach. Aim: in this review, we aim at evaluating the various ways of approaching patients who suffer from type-one diabetes during ketoacidosis and keto-acidotic coma. We will try to understand the triggers and pathophysiology behind this condition, and explore ways to prevent them.
Conclusion: prompt diagnoses, aggressive treatment, and education of patient and their care providers about prevention strategies must be implemented. Also, more studies are required in the area of preventing health complications due to these types of diseases to effectively manage DKA in the future.
 
 
Keywords
diabetic ketoacidosis approach; insulin therapy in diabetic ketoacidosis; fluid replacement in diabetic ketoacidosis
Statistics
Article View: 323
PDF Download: 414